XORTX Therapeutics Inc. announced that its previously declared share consolidation of one new share for every five old shares will become effective on April 6, 2026, following receipt of required exchange approvals.
Key takeaways
Share consolidation ratio is set at 1 new common share for every 5 old common shares, reducing the share count significantly.
The consolidation has received all required approvals from both the TSX Venture Exchange and the Nasdaq Stock Exchange.
The effective date for the share consolidation is confirmed for April 6, 2026.
This action follows the Company's initial announcement regarding the consolidation released on March 26, 2026.